You Make the Call

You Make the Call

Each month we’ll pick a challenging clinical question submitted through the Consult-a-Colleague program and post the expert’s response.

You Make the Call

You Make the Call: How would you treat this 38-year-old patient with sickle cell trait...

This month, Maureen Achebe, MD, MPH, discusses treatment for a patient with sickle cell trait and end-stage renal disease. And don't forget to check out...
You Make the Call

You Make the Call: Should a mostly asymptomatic patient with amyloidosis receive systemic therapy?

This month Morie A. Gertz, MD, discusses whether a mostly asymptomatic patient with amyloidosis should receive systemic therapy. And don't forget to check out next...
You Make the Call

You Make the Call: How long should a young patient with COVID-19 and pulmonary...

This month, Caroline Berube, MD, discusses anticoagulation for a young patient with COVID-19 and pulmonary embolism. And don't forget to check out next month's clinical...
You Make the Call

You Make the Call: How would you treat a patient with aggressive systemic mastocytosis?

This month, William Shomali, MD, discusses treatment of bone manifestations and transplantation for systemic mastocytosis. And don't forget to check out next month's clinical dilemma...
You Make the Call

You Make the Call: How would you treat this patient with poor cytogenetics and...

This month, Jorge Castillo, MD, discusses treatment of low-grade B-cell lymphoma with high-risk cytogenetics. And don't forget to check out next month's clinical dilemma - send...
You Make the Call

You Make the Call: Which direct oral anticoagulant would you choose for a saddle...

This month, Allyson Pishko, MD, MSCE, discusses choice of direct oral anticoagulant (DOAC) for a saddle pulmonary embolism. And don't forget to check out next...
You Make the Call

You Make the Call: How would you treat this patient with JAK2-positive essential thrombocythemia?

This month, Ruben Mesa, MD, discusses anticoagulation in a patient with essential thrombocythemia. And don't forget to check out next month's clinical dilemma - send...
You Make the Call

You Make the Call: Can I start cytoreductive therapy in a patient with low-risk...

This month, Ayalew Tefferi, MD, discusses cytoreductive therapy in a patient with low-risk polycythemia vera. And don't forget to check out next month's clinical dilemma...
You Make the Call

You Make the Call: Is hypogammaglobulinemia alone an indication for treatment for CLL?

This month, Ariela Noy, MD, discusses whether hypogammaglobulinemia alone is an indication for treatment of CLL. And don't forget to check out next month's clinical...
You Make the Call

You Make the Call: Is 3 months of anticoagulation enough for a provoked VTE?

This month, Keith McCrae, MD, discusses the appropriate length of anticoagulation for a provoked DVT. And don't forget to check out next month's clinical dilemma...
Advertisement

Current Issue

June 2021 Volume 7 Issue 7

This issue reviews the management and prevention of peripheral neuropathy, early successes of SCD screening programs in sub-Saharan Africa, and more.

Block title